Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

PANCREATIC CANCER

Chemokines: the (un)usual suspects in pancreatic cancer neural invasion

Pancreatic cancer is notorious for its affinity for invading nerves. A new study using a systematic unbiased RNA-interference screen of neuronal chemokines in cocultures of mouse sensory neurons and pancreatic cancer cells has now identified CCL21 and CXCL10 as key mediators of neural invasion, neural remodelling and pain in pancreatic cancer.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Chemokines mediate a vicious cycle between sensory neurons and pancreatic cancer cells.

References

  1. Liebl, F. et al. The impact of neural invasion severity in gastrointestinal malignancies: a clinicopathological study. Ann. Surg. 260, 900–907 (2014).

    Article  Google Scholar 

  2. Amit, M. et al. Upregulation of RET induces perineurial invasion of pancreatic adenocarcinoma. Oncogene 36, 3232–3239 (2017).

    Article  CAS  Google Scholar 

  3. Gil, Z. et al. Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves. J. Natl Cancer Inst. 102, 107–118 (2010).

    Article  CAS  Google Scholar 

  4. Demir, I. E. et al. Investigation of Schwann cells at neoplastic cell sites before the onset of cancer invasion. J. Natl Cancer Inst. 106, dju184 (2014).

    Article  Google Scholar 

  5. Deborde, S. et al. Schwann cells induce cancer cell dispersion and invasion. J. Clin. Invest. 126, 1538–54 (2016).

    Article  Google Scholar 

  6. Demir, I. E. et al. Early pancreatic cancer lesions suppress pain through CXCL12-mediated chemoattraction of Schwann cells. Proc. Natl Acad. Sci. USA 114, E85–E94 (2017).

    Article  CAS  Google Scholar 

  7. Na’ara, S., Amit, M. & Gil, Z. L1CAM induces perineural invasion of pancreas cancer cells by upregulation of metalloproteinase expression. Oncogene 38, 596–608 (2019).

    Article  Google Scholar 

  8. Hirth, M. et al. CXCL10 and CCL21 promote migration of pancreatic cancer cells toward sensory neurons and neural remodeling in tumors in mice, associated with pain in patients. Gastroenterology https://doi.org/10.1053/j.gastro.2020.04.037 (2020).

    Article  PubMed  Google Scholar 

  9. Ceyhan, G. O. et al. Pancreatic neuropathy and neuropathic pain — a comprehensive pathomorphological study of 546 cases. Gastroenterology 136, 177–186 (2009).

    Article  Google Scholar 

  10. Marchesi, F. et al. The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma. Cancer Res. 68, 9060–9069 (2008).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ihsan Ekin Demir.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Demir, I.E., Mota Reyes, C. Chemokines: the (un)usual suspects in pancreatic cancer neural invasion. Nat Rev Gastroenterol Hepatol 18, 221–222 (2021). https://doi.org/10.1038/s41575-020-0329-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41575-020-0329-1

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing